Profile & Mission


Science-based, science-serving

MILabs was founded in 2006 by Prof. Freek Beekman as a molecular imaging spin-off from the University Medical Centre Utrecht, the Netherlands. Today, the company is one of the global leaders in molecular imaging with the development of high-performance preclinical micro-PET, micro-SPECT, micro-CT, and Optical Tomography systems. These imaging systems have received many international awards from the physics and molecular imaging community. Currently, MILabs’ imaging devices support the research of many hundreds of satisfied users worldwide at universities, CRO’s and pharmaceutical companies.

Unmatched quality through continuous improvements

MILabs achieved its first commercial success with the U-SPECT and U-SPECT/CT systems, which today deliver sub-quarter-mm resolution in-vivo images of radiolabeled tracers. There has been a continuum of new developments that further improved the performance and functionality of these small animal imaging systems. In 2013, MILabs introduced VECTor, an extremely user-friendly, fully integrated multimodal SPECT, PET and CT imaging technology that provides simultaneously sub-mm resolution  PET and  SPECT acquisition. In 2015 MILabs launched U-CT, a best-in-class preclinical in-vivo micro-CT scanner, which provides unprecedented resolution, low dose imaging capabilities, and outstanding scanning speed. This high-performance micro-CT is also an integrated part of MILabs’ multimodal U-SPECT/CT, U-PET/CT, OI/CT, and PET/SPECT/CT  systems. In 2018, MILabs launched 3D autoradiography and optical tomography modules for which MILabs again received the WMIC Innovation of the Year Award.  Customers can now order SPECT, PET, bioluminescence & fluorescence planar and tomography, 3D Autoradiography and micro-CT as either single-modality systems or fully integrated in any combination on a multimodality imaging platform. The latest PET technology has a positron range free prompt PET option that allows to image isotopes like 89Zr, 82Rb or 124I at 0.75mm resolution and enables simultaneous dual-isotope PET.

Latest technologies for arguably the best ever achieved in vivo imaging performance

MILabs molecular imaging systems are built in different base configurations to best meet the researcher’s application needs, offering exceptional performance, cost-effectiveness, and extremely high reliability. Whether offered as stand-alone units or in multimodal imaging configurations, MILabs is truly pushing the performance limits in terms of image quality and in-vivo imaging functionality. With proven 0.12 mm resolution ex-vivo SPECT, 0.25 mm in vivo SPECT, and 0.6 mm in vivo PET resolution, nuclear imaging performance is currently approaching physical limits. Complemented by micro-CT and Optical Imaging with unique autonomous operation on an integrated multi-modal platform, preclinical imaging with a MILabs system is guided by a simple, intuitive and user-friendly operation to ensure highly efficient workflows, including single-pass PET, SPECT, bioluminescence & fluorescence tomography and CT imaging of small animals with a single dose of anesthesia and without having to shuttle animals between molecular imaging modalities.

Meet Us At

Scroll to Top